Wuhan Hhd Supply Fucoxanthin Seaweed Extract Powder

Name: Wuhan Hhd Supply Fucoxanthin Seaweed Extract Powder
Brand: Wuhan Hengheda Pharm Co., Ltd.
SKU: 1923444975

Hubei, ChinaWuhan Hengheda Pharm Co., Ltd.

US$1.00-2.00

100 Pieces

Product profile

Customization

Available

Powder

Yes

Customized

Non-Customized

Certification

Enterprise Standards

Suitable for

Adult

State

Powder

Purity

>98%

Color

White

Grade

Pharmaceutical Grade

Transport Package

Alumininum Foli Bags

Specification

10g, 50g, 200g, 1kg, 5kg

Trademark

hhdpharm

Origin

China

Company profile

Importers and ExportersFull CustomizationODM ServicesQuality Assurance

Wuhan Hengheda Pharm Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Full Customization CertifiedExport Year: 15 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤8.27h

AI-Powered supplier vetting

SummaryWuhan Hengheda Pharm Co., Ltd. is a China-based limited manufacturing company established in 2013, with 27 employees and operations in Hubei. It specializes in pharmaceutical intermediates, APIs, fine chemicals, natural extracts, food additives, health-related products, custom synthesis, and related OEM services. The supplier reports a 1,000-square-meter R&D and pilot-scale platform, three production lines, and a cooperative production base with 50L–2,000L reaction vessels and tonnage-level R&D and production capacity. It exports 41%–50% of total sales and began exporting in 2012. An SGS audit is recorded, but the audit result is coded as 0 and the stated validity period ended on 2025-07-21; the meaning of the result code is not provided. Most service, quality-system, customer-case, and certification details remain unknown, so several fields cannot be conclusively assessed.

Supplier typeThe supplier is identified as Wuhan Hengheda Pharm Co., Ltd., a Chinese limited company and factory located in Hubei. Its stated business focuses on custom synthesis, manufacture, and import/export of fine chemicals, APIs, and pharmaceutical intermediates.

R&D capabilityThe supplier reports a 1,000-square-meter R&D and pilot-scale platform with modern experimental equipment and the ability to conduct small-scale research and pilot production of compounds. The records also state two years of R&D engineer experience, but product-launch, ODM, SDK, and other innovation indicators are unknown.

Production capacityThe supplier reports three production lines and a cooperative production base exceeding 30 mu, equipped with stainless-steel and glass-lined vessels ranging from 50L to 2,000L. It states that the base supports tonnage-level R&D and production, providing explicit evidence of substantial production infrastructure.

Customization capabilityCustom synthesis is listed among the supplier's primary offerings, and the company describes R&D and pilot-scale capabilities for producing various compounds. These statements directly support customization for chemical and pharmaceutical-related products, although specific project examples and service procedures are not provided.